Benjamin P. Linas, MD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Linas is a national leader in hepatitis-C virus (HCV) infection and HCV/HIV co-infection comparative- and cost-effectiveness research using computational biology, clinical epidemiology and clinical economics methods. Dr. Linas has an excellent track record of productivity, ample funding from the NIH and CDC, and a growing core of successful trainees. Dr. Linas directs the HIV/HCV core of the Center for Health Economics of Treatment Interventions for Substance Use Disorders, HCV, and HIV, funded by the National Institute on Drug Abuse (NIDA) in collaboration with Cornell, U Penn and Miami.

Publications

  • Published 5/20/2026

    Linas BP. Centering AIDS Drug Assistance Programs in the US HIV Response. Clin Infect Dis. 2026 May 20; 82(5):e974-e975. PMID: 41877605.

    Read at: PubMed

  • Published 5/4/2026

    Gallini J, Singh UB, Dauphinais M, Sarkar S, Carwile M, Kumar R, Rao R, Chaudhary A, McQuaid CF, Maloomian K, Sinha S, Mehta S, Dowdy DW, Liu AF, Linas BP, Horsburgh CR, White LF, Sinha P. Cost-effectiveness of in-kind nutritional support for impoverished persons with tuberculosis to reduce mortality and disengagement from care in India: a modelling study. BMJ Glob Health. 2026 May 04; 11(5). PMID: 42082204.

    Read at: PubMed

  • Published 5/1/2026

    Zhu L, Magaldi LN, Wagh IA, Ennis ER, Reitsma MB, Kuncio DE, Addish E, Varghese SR, Furukawa NW, Honeycutt AA, Chen Y, Linas BP, Salomon JA. Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies. JAMA Intern Med. 2026 May 01; 186(5):585-595. PMID: 41870443.

    Read at: PubMed

  • Published 4/30/2026

    Chhatwal J, Sahinkoc M, Chen Q, Dowd W, Xiao J, Zarkin GA, Aldridge A, Barocas JA, Cerdá M, Fareed N, Frazier LA, Hyder A, Keyes KM, Knott CE, LaRochelle M, Linas BP, Oga E, Roberts SM, Samet JH, Schackman BR, Seiber EE, Starbird LE, Villani J, Knudsen AB, Barbosa C. Cost-effectiveness of community-based interventions for reducing opioid overdose and non-overdose deaths: simulation modeling of HEALing Communities Study. Lancet Reg Health Am. 2026 Jul; 59:101480. PMID: 42099551.

    Read at: PubMed

  • Published 4/27/2026

    Lind ML, Hitchings MDT, Singh RP, Linas BP, Cummings DAT, Epstein RL. Impact of Removing the Universal Hepatitis B Birth-Dose Vaccination in the US. JAMA Pediatr. 2026 Apr 27. PMID: 42043807.

    Read at: PubMed

View All 209 Publications:   View Full Profile in BUMC

Other Positions

  • Professor, Epidemiology
    Boston University School of Public Health

Websites

Education

  • New York University School of Medicine, MD
  • Harvard School of Public Health, MPH
  • Yale University, BA

View all profiles